Literature DB >> 6749586

Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus.

W Waldhäusl, P Bratusch-Marrain, S Gasić, A Korn, P Nowotny.   

Abstract

To differentiate peripheral and hepatic insulin resistance in hyperinsulinaemic overweight Type 2 (non-insulin-dependent) diabetic patients (n = 17; 143 +/- 4% ideal body weight; mean +/- SEM) arterial concentrations and splanchnic exchange of glucose, pyruvate, lactate, non-esterified fatty acids, beta-hydroxybutyrate and acetoacetate, as well as the insulin production rate, were determined before and during oral glucose loads of 25 g or 100 g. Insulin production rate, hepatic insulin retention and splanchnic exchange of glucose and metabolites were estimated by means of the hepatic venous catheter technique. In the basal state insulin production rate was greater in overweight Type 2 diabetic patients (2.57 +/- 0.28 pmol.kg-1. min-1) than in healthy control subjects (1.68 +/- 0.17 pmol.kg-1.min-1; p less than 0.01). After ingestion of 25 g glucose, the cumulative insulin production rate exceeded normal values (p less than 0.05), but was below normal with 100 g glucose (p less than 0.01). Relative insulin trapping by the splanchnic bed in the diabetic patients was 54 +/- 3%, not different from normal. Following a 100 g glucose load, splanchnic insulin retention fell by 20% in the patients, and less consistently so in healthy controls. Splanchnic glucose output was normal in the diabetic patients both in the basal state and after glucose ingestion although the induced arterial blood glucose levels were greater in the diabetic patients than in control subjects (p less than 0.005). Splanchnic output of pyruvate (p less than 0.025), lactate (p less than 0.01), and beta-hydroxybutyrate (p less than 0.005) were greater in the basal state in the diabetic patients than in healthy subjects. However, no difference in splanchnic exchange was seen between the two groups in their metabolites' respective response to glucose ingestion. These data suggest that obese hyperinsulinaemic Type 2 diabetic patients may represent a subgroup of diabetic patients with predominantly peripheral, but compensated hepatic, insulin resistance being associated with an increased basal insulin production rate which only exhausts after ingestion of a large glucose load.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6749586     DOI: 10.1007/BF00257722

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  46 in total

Review 1.  The role of insulin resistance in the pathogenesis of diabetes mellitus.

Authors:  G M Reaven; J M Olefsky
Journal:  Adv Metab Disord       Date:  1978

2.  Excessive serum insulin response to oral glucose in obesity and mild diabetes. Study of 501 patients.

Authors:  R Chiles; M Tzagournis
Journal:  Diabetes       Date:  1970-06       Impact factor: 9.461

3.  Study of the relationship between glucose and insulin responses to an oral glucose load in man.

Authors:  G Reaven; R Miller
Journal:  Diabetes       Date:  1968-09       Impact factor: 9.461

4.  Glucose intolerance and aging: evidence for tissue insensitivity to insulin.

Authors:  R A Defronzo
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

5.  Hormonal control of ketogenesis. Biochemical considerations.

Authors:  J D McGarry; D W Foster
Journal:  Arch Intern Med       Date:  1977-04

6.  C-peptide metabolism and the liver.

Authors:  C Kühl; O K Faber; P Hornnes; S L Jensen
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

7.  Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasic; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

8.  Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.

Authors:  J E Liljenquist; G L Mueller; A D Cherrington; J M Perry; D Rabinowitz
Journal:  J Clin Endocrinol Metab       Date:  1979-01       Impact factor: 5.958

9.  Biologic gastric emptying time in diabetic patients, using Tc-99m-labeled resin-oatmeal with and without metoclopramide.

Authors:  P A Domstad; E E Kim; J J Coupal; R Beihn; S Yonts; Y C Choy; P Mandelstam; F H DeLand
Journal:  J Nucl Med       Date:  1980-11       Impact factor: 10.057

10.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

View more
  20 in total

Review 1.  The role of the liver in type 2 diabetes.

Authors:  Peter Staehr; Ole Hother-Nielsen; Henning Beck-Nielsen
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 2.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.

Authors:  K Ratheiser; W Reitgruber; M Komjati; P Bratusch-Marrain; H Vierhapper; W K Waldhäusl
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

Review 4.  Metabolic and molecular basis of insulin resistance.

Authors:  Mandeep Bajaj; Ralph A Defronzo
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

5.  Blood lactate behavior after glucose load in diabetes mellitus.

Authors:  R Prando; V Cheli; P Buzzo; P Melga; E Ansaldi; S Accoto
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

Review 6.  Role of the kidney in hyperglycemia in type 2 diabetes.

Authors:  Christian Meyer; John E Gerich
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

7.  Factors affecting fasting serum C-peptide levels in Micronesians: comparison with a Caucasoid population.

Authors:  P Garcia-Webb; P Zimmet; A Bonser; H King; S Bottomley
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

Review 8.  11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.

Authors:  T M Stulnig; W Waldhäusl
Journal:  Diabetologia       Date:  2003-12-03       Impact factor: 10.122

9.  The measurement and validation of the nonsteady-state rates of C-peptide appearance in the dog.

Authors:  T Morishima; S Pye; K Polonsky; J Radziuk
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

10.  Basal and 24-h C-peptide and insulin secretion rate in normal man.

Authors:  Y T Kruszynska; P D Home; I Hanning; K G Alberti
Journal:  Diabetologia       Date:  1987-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.